Logo image of IRBT

IROBOT CORP (IRBT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IRBT - US4627261005 - Common Stock

1.69 USD
+0.11 (+6.96%)
Last: 12/1/2025, 4:16:09 PM
1.39 USD
-0.3 (-17.75%)
After Hours: 12/1/2025, 4:16:09 PM
Fundamental Rating

1

IRBT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 61 industry peers in the Household Durables industry. IRBT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, IRBT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IRBT has reported negative net income.
IRBT had a negative operating cash flow in the past year.
In multiple years IRBT reported negative net income over the last 5 years.
IRBT had negative operating cash flow in 4 of the past 5 years.
IRBT Yearly Net Income VS EBIT VS OCF VS FCFIRBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

The Return On Assets of IRBT (-43.34%) is worse than 95.08% of its industry peers.
Industry RankSector Rank
ROA -43.34%
ROE N/A
ROIC N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
IRBT Yearly ROA, ROE, ROICIRBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

IRBT has a worse Gross Margin (23.24%) than 62.30% of its industry peers.
In the last couple of years the Gross Margin of IRBT has declined.
The Profit Margin and Operating Margin are not available for IRBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
IRBT Yearly Profit, Operating, Gross MarginsIRBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IRBT has more shares outstanding
Compared to 5 years ago, IRBT has more shares outstanding
Compared to 1 year ago, IRBT has a worse debt to assets ratio.
IRBT Yearly Shares OutstandingIRBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IRBT Yearly Total Debt VS Total AssetsIRBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -1.47, we must say that IRBT is in the distress zone and has some risk of bankruptcy.
IRBT has a Altman-Z score of -1.47. This is amonst the worse of the industry: IRBT underperforms 93.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.47
ROIC/WACCN/A
WACC10.16%
IRBT Yearly LT Debt VS Equity VS FCFIRBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

IRBT has a Current Ratio of 0.52. This is a bad value and indicates that IRBT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of IRBT (0.52) is worse than 96.72% of its industry peers.
A Quick Ratio of 0.22 indicates that IRBT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.22, IRBT is doing worse than 96.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.22
IRBT Yearly Current Assets VS Current LiabilitesIRBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.58% over the past year.
The Revenue for IRBT has decreased by -33.08% in the past year. This is quite bad
The Revenue for IRBT have been decreasing by -10.90% on average. This is quite bad
EPS 1Y (TTM)14.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-866.67%
Revenue 1Y (TTM)-33.08%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-24.63%

3.2 Future

The Earnings Per Share is expected to grow by 33.99% on average over the next years. This is a very strong growth
Based on estimates for the next years, IRBT will show a quite strong growth in Revenue. The Revenue will grow by 9.89% on average per year.
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IRBT Yearly Revenue VS EstimatesIRBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
IRBT Yearly EPS VS EstimatesIRBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IRBT. In the last year negative earnings were reported.
Also next year IRBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRBT Price Earnings VS Forward Price EarningsIRBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRBT Per share dataIRBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as IRBT's earnings are expected to grow with 33.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.99%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IRBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IROBOT CORP

NASDAQ:IRBT (12/1/2025, 4:16:09 PM)

After market: 1.39 -0.3 (-17.75%)

1.69

+0.11 (+6.96%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)05-04 2026-05-04
Inst Owners44.53%
Inst Owner Change-11.46%
Ins Owners3.32%
Ins Owner Change18.48%
Market Cap53.79M
Revenue(TTM)547.00M
Net Income(TTM)-208.72M
Analysts43.33
Price TargetN/A
Short Float %33.44%
Short Ratio2.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)70.84%
Min EPS beat(2)65.31%
Max EPS beat(2)76.37%
EPS beat(4)2
Avg EPS beat(4)18.52%
Min EPS beat(4)-50.53%
Max EPS beat(4)76.37%
EPS beat(8)5
Avg EPS beat(8)32.32%
EPS beat(12)6
Avg EPS beat(12)-56.92%
EPS beat(16)8
Avg EPS beat(16)-48.15%
Revenue beat(2)2
Avg Revenue beat(2)2.57%
Min Revenue beat(2)0.05%
Max Revenue beat(2)5.1%
Revenue beat(4)2
Avg Revenue beat(4)-5.48%
Min Revenue beat(4)-20.34%
Max Revenue beat(4)5.1%
Revenue beat(8)3
Avg Revenue beat(8)-4.9%
Revenue beat(12)4
Avg Revenue beat(12)-8.65%
Revenue beat(16)4
Avg Revenue beat(16)-10.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.51
EYN/A
EPS(NY)-1.13
Fwd EYN/A
FCF(TTM)-3.36
FCFYN/A
OCF(TTM)-3.36
OCFYN/A
SpS17.18
BVpS-0.84
TBVpS-6.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.24%
FCFM N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.22
Altman-Z -1.47
F-Score4
WACC10.16%
ROIC/WACCN/A
Cap/Depr(3y)11.65%
Cap/Depr(5y)43.11%
Cap/Sales(3y)0.46%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-866.67%
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.08%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-24.63%
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-104.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4377.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1288.32%
OCF growth 3YN/A
OCF growth 5YN/A

IROBOT CORP / IRBT FAQ

What is the fundamental rating for IRBT stock?

ChartMill assigns a fundamental rating of 1 / 10 to IRBT.


Can you provide the valuation status for IROBOT CORP?

ChartMill assigns a valuation rating of 1 / 10 to IROBOT CORP (IRBT). This can be considered as Overvalued.


How profitable is IROBOT CORP (IRBT) stock?

IROBOT CORP (IRBT) has a profitability rating of 0 / 10.


How financially healthy is IROBOT CORP?

The financial health rating of IROBOT CORP (IRBT) is 0 / 10.